FDA Hired An Independent Contractor To Analyze Plan B Comments, Von Eschenbach Says
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA Acting Commissioner ducks questions from Rep. Sam Farr (D-Calif.) on a timeline for Plan B's OTC switch.